Management of Herpes Simplex Virus Stromal Keratitis: An Evidence-based Review

Survey of Ophthalmology

Volumn 54, Issue 2, 2009, Pages 226-234

  Knickelbein, Jared E ^a   Hendricks, Robert L ^a   Charukamnoetkanok, Puwat ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

amniotic membrane transplantation; cyclosporine A; herpes simplex virus vaccine; herpes stromal keratitis pathogenesis; herpes stromal keratitis treatment

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN A; HSV 1 VACCINE; PLACEBO; PREDNISOLONE; TRIFLURIDINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; CATARACT; CELL TRANSPLANTATION; CLINICAL TRIAL; HERPES SIMPLEX VIRUS; HUMAN; KERATOPLASTY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; VACCINATION; VIRUS KERATITIS;

AMNION; ANTIVIRAL AGENTS; CORNEAL STROMA; CYCLOSPORINE; GLUCOCORTICOIDS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS, HERPETIC;

EID: 61949478531     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2008.12.004     Document Type: Article

References (78)

1. -. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 339 5 (1998) 300-306
2. -. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group. Cornea 20 2 (2001) 123-128
3. Barker N.H. Ocular herpes simplex. Clin Evid 15 (2006) 917-923
4. Barron B.A., Gee L., Hauck W.W., et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 101 12 (1994) 1871-1882
5. Bettahi I., Nesburn A.B., Yoon S., et al. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Invest Ophthalmol Vis Sci 48 10 (2007) 4643-4653
6. Bouchard C.S., and John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocul Surf 2 3 (2004) 201-211
7. Brik D., Dunkel E., and Pavan-Langston D. Herpetic keratitis: persistence of viral particles despite topical and systemic antiviral therapy. Report of two cases and review of the literature. Arch Ophthalmol 111 4 (1993) 522-527
8. Carnahan M.C., and Goldstein D.A. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 11 6 (2000) 478-483
9. Choi T.H., and Tseng S.C. In vivo and in vitro demonstration of epithelial cell-induced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane. Cornea 20 2 (2001) 197-204
10. Collum L.M., Logan P., and Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis. Br J Ophthalmol 67 2 (1983) 115-118
11. Collum L.M., and Grant D.M. A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis. Curr Eye Res 6 1 (1987) 221-224
12. Corey L., Langenberg A.G., Ashley R., et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. Jama 282 4 (1999) 331-340
13. de Bruyn G., Vargas-Cortez M., Warren T., et al. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine 24 7 (2006) 914-920
14. Deshpande S., Zheng M., Lee S., et al. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol 167 5 (2001) 2902-2910
15. Dua H.S., Gomes J.A., King A.J., and Maharajan V.S. The amniotic membrane in ophthalmology. Surv Ophthalmol 49 1 (2004) 51-77
16. Easty D.L., Shimeld C., Claoue C.M., and Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res 6 1 (1987) 69-74
17. Field A.J., and Gottsch J.D. Persisting epithelial herpes simplex keratitis while on cyclosporin-A ointment. Aust NZ J Ophthalmol 23 4 (1995) 333-334
18. Fukuda M., Deai T., Hibino T., et al. Quantitative analysis of herpes simplex virus genome in tears from patients with herpetic keratitis. Cornea 22 7 Suppl (2003) S55-S60
19. Gaudio P.A. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Inflamm 12 3 (2004) 169-192
20. Gunduz K., and Ozdemir O. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis. Ophthalmic Res 29 6 (1997) 405-408
21. Heiligenhaus A., and Steuhl K.P. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study. Graefes Arch Clin Exp Ophthalmol 237 5 (1999) 435-438
22. Heiligenhaus A., Bauer D., Meller D., et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci 42 9 (2001) 1969-1974
23. Heiligenhaus A., Li H., Hernandez Galindo E.E., et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation. Br J Ophthalmol 87 10 (2003) 1215-1219
24. Hendricks R.L., and Tumpey T.M. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest Ophthalmol Vis Sci 31 10 (1990) 1929-1939
25. Hernandez G.L., Volpert O.V., Iniguez M.A., et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193 5 (2001) 607-620
26. Holbach L.M., Font R.L., and Naumann G.O. Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet's membrane, the stroma, and Bowman's layer. Ophthalmology 97 6 (1990) 722-728
27. Holbach L.M., Font R.L., Baehr W., and Pittler S.J. HSV antigens and HSV DNA in avascular and vascularized lesions of human herpes simplex keratitis. Curr Eye Res 10 Suppl (1991) 63-68
28. Holland E.J., and Schwartz G.S. Classification of herpes simplex virus keratitis. Cornea 18 2 (1999) 144-154
29. Kashani S., and Mearza A.A. Uses and safety profile of ciclosporin in ophthalmology. Expert Opin Drug Saf 7 1 (2008) 79-89
30. Keelan J.A., Zhou R.L., and Mitchell M.D. Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues. Placenta 21 1 (2000) 38-43
31. Khanna K.M., Bonneau R.H., Kinchington P.R., and Hendricks R.L. Herpes simplex virus-specific memory CD8 + T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18 5 (2003) 593-603
32. Khokhar S., Natung T., Sony P., et al. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea 24 6 (2005) 654-660
33. Kim J.S., Kim J.C., Na B.K., et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 70 3 (2000) 329-337
34. Knickelbein J.E., Khanna K.M., Yee M.B., et al. Noncytotoxic lytic granule-mediated CD8 + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322 5899 (2008) 268-271
35. Kobayashi N., Kabuyama Y., Sasaki S., et al. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea 21 1 (2002) 62-67
36. Labetoulle M., Auquier P., Conrad H., et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology 112 5 (2005) 888-895
37. Lepisto A.J., Frank G.M., and Hendricks R.L. How herpes simplex virus type 1 rescinds corneal privilege. Chem Immunol Allergy 92 (2007) 203-212
38. Li H., Niederkorn J.Y., Neelam S., et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46 3 (2005) 900-907
39. Liesegang T.J. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107 8 (1989) 1160-1165
40. Liesegang T.J., Melton III L.J., Daly P.J., and Ilstrup D.M. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107 8 (1989) 1155-1159
41. Liesegang T.J. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18 2 (1999) 127-143
42. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 20 1 (2001) 1-13
43. Lipman R.M., Epstein R.J., and Hendricks R.L. Suppression of corneal neovascularization with cyclosporine. Arch Ophthalmol 110 3 (1992) 405-407
44. Liu T., Khanna K.M., Chen X., et al. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191 9 (2000) 1459-1466
45. McGhee C.N., Dean S., and Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf 25 1 (2002) 33-55
46. Metcalf J.F., Hamilton D.S., and Reichert R.W. Herpetic keratitis in athymic (nude) mice. Infect Immun 26 3 (1979) 1164-1171
47. Miserocchi E., Waheed N.K., Dios E., et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology 109 8 (2002) 1532-1537
48. Norn M.S., and Dendritic (herpetic) keratitis I. Incidence, seasonal variations, recurrence rate, visual impairment, therapy. Acta Ophthalmol (Copenh) 48 1 (1970) 91-107
49. Orr M.T., Orgun N.N., Wilson C.B., and Way S.S. Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection. J Immunol 178 8 (2007) 4731-4735
50. Pavan-Langston D. In: Ra S. (Ed). Herpes Simplex of the Ocular Anterior Segment (2000), Blackwell Science, Inc., Malden, MA
51. Pepose J.S., Keadle T.L., and Morrison L.A. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 141 3 (2006) 547-557
52. Petraglia F., Anceschi M.M., Calza L., et al. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 77 2 (1993) 542-548
53. Pivetti-Pezzi P., Accorinti M., Colabelli-Gisoldi R.A., et al. Herpes simplex virus vaccine in recurrent herpetic ocular infection. Cornea 18 1 (1999) 47-51
54. Power W.J., Hillery M.P., Benedict-Smith A., and Collum L.M. Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis. Br J Ophthalmol 76 12 (1992) 711-713
55. Price D.J., Grove J.R., Calvo V., et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257 5072 (1992) 973-977
56. Rao S.N. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol 141 4 (2006) 771-772
57. Romero R., Gomez R., Galasso M., et al. The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection. Am J Obstet Gynecol 171 4 (1994) 912-921
58. Russell R.G., Nasisse M.P., Larsen H.S., and Rouse B.T. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 25 8 (1984) 938-944
59. Schreiber S.L., and Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol Today 13 4 (1992) 136-142
60. Sheridan B.S., Knickelbein J.E., and Hendricks R.L. CD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Expert Opin Biol Ther 7 9 (2007) 1323-1331
61. Shi W., Chen M., and Xie L. Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis. Ophthalmology 114 8 (2007) 1476-1481
62. Shimomura Y., Deai T., Fukuda M., et al. Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 26 2 (2007) 190-193
63. Sigal N.H., and Dumont F.J. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10 (1992) 519-560
64. Solomon A., Rosenblatt M., Monroy D., et al. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 85 4 (2001) 444-449
65. Straus S.E., Wald A., Kost R.G., et al. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Infect Dis 176 5 (1997) 1129-1134
66. Streilein J.W., Dana M.R., and Ksander B.R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 18 9 (1997) 443-449
67. Tamhane A., Vajpayee R.B., Biswas N.R., et al. Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology 112 11 (2005) 1963-1969
68. Theil D., Derfuss T., Paripovic I., et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 163 6 (2003) 2179-2184
69. Tseng S.C. Amniotic membrane transplantation for ocular surface reconstruction. Biosci Rep 21 4 (2001) 481-489
70. Tseng S.C., Espana E.M., Kawakita T., et al. How does amniotic membrane work?. Ocul Surf 2 3 (2004) 177-187
71. Tullo A.B., Easty D.L., Shimeld C., et al. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. Trans Ophthalmol Soc UK 104 Pt 2 (1985) 159-165
72. Verjans G.M., Hintzen R.Q., van Dun J.M., et al. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci USA 104 9 (2007) 3496-3501
73. Wiederrecht G., Lam E., Hung S., et al. The mechanism of action of FK-506 and cyclosporin A. Ann NY Acad Sci 696 (1993) 9-19
74. Wilhelmus K.R. Diagnosis and management of herpes simplex stromal keratitis. Cornea 6 4 (1987) 286-291
75. Wilhelmus K.R., Gee L., Hauck W.W., et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 101 12 (1994) 1883-1895 discussion 95-6
76. Wilhelmus K.R. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 1 (2007) CD002898
77. Yoon K.C., Heo H., Kang I.S., et al. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model. Cornea 27 4 (2008) 454-460
78. Zheng M., Deshpande S., Lee S., et al. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 75 20 (2001) 9828-9835